Clinical Trial Update: Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase II pharmacodynamic study evaluated the effect of bardoxolone methyl on estimated glomerular filtration rate (eGFR) in adults with type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Renal Insufficiency, Chronic, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED